Patient Safety Risks from AI Scribes: Signals from End-User Feedback
Jessica Dai, Anwen Huang, Catherine Nasrallah, Rhiannon Croci, Hossein Soleimani, Sarah J. Pollet, Julia Adler-Milstein, Sara G. Murray, Jinoos Yazdany, Irene Y. Chen
TL;DR
The study investigates patient safety risks associated with AI scribes by analyzing end-user feedback from a large U.S. hospital system. It employs a mixed-methods design combining quantitative per-encounter feedback analysis (BERTopic/Sentence-BERT) and qualitative provider surveys to identify safety signals and understand clinician perceptions. Findings indicate safety concerns related to medication transcription, HPI/A/P documentation, and other note-formation processes, though heterogeneity among clinicians and the limited sample size limit prevalence estimates. The authors argue that end-user feedback can serve as a real-time monitoring signal for deployment of AI scribes and highlight methodological considerations for handling one-sided feedback. The work lays groundwork for automated safety-signal systems in clinical AI deployments.
Abstract
AI scribes are transforming clinical documentation at scale. However, their real-world performance remains understudied, especially regarding their impacts on patient safety. To this end, we initiate a mixed-methods study of patient safety issues raised in feedback submitted by AI scribe users (healthcare providers) in a large U.S. hospital system. Both quantitative and qualitative analysis suggest that AI scribes may induce various patient safety risks due to errors in transcription, most significantly regarding medication and treatment; however, further study is needed to contextualize the absolute degree of risk.
